Regencell Bioscience Holdings (RGC) Enterprise Value (2020 - 2025)
Regencell Bioscience Holdings' (RGC) quarterly Enterprise Value came in at -$2.5 million in Q2 2025, up 68.88% YoY from -$1.5 million in Q2 2024, and up 68.88% on a QoQ basis from -$8.0 million in Q2 2024.
Regencell Bioscience Holdings (RGC) Enterprise Value (2020 - 2025) Analysis & Trends
Regencell Bioscience Holdings (RGC) has 6 years of Enterprise Value data on file, last reported at -$2.5 million in Q2 2025.
- Quarterly Enterprise Value rose 68.88% year-over-year to -$2.5 million in Q2 2025, while the trailing twelve-month figure through Jun 2024 was -$8.0 million (up 31.4% YoY) and the FY2025 annual result came in at -$2.5 million, up 68.88% from the prior year.
- Enterprise Value climbed to -$2.5 million in Q2 2025, from -$8.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$59413.0 in Q2 2021 to a low of -$16.4 million in Q2 2022.
- A 5-year average of -$7.7 million and a median of -$8.0 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value surged 84.65% — and 2022, when it sank 27506.1%.
- Tracing RGC's Enterprise Value over 5 years: stood at -$59413.0 in 2021, then slumped by 27506.1% to -$16.4 million in 2022, then advanced by 29.24% to -$11.6 million in 2023, then soared by 31.4% to -$8.0 million in 2024, then jumped by 68.88% to -$2.5 million in 2025.
- The last three Enterprise Value figures came in at -$2.5 million (Q2 2025), -$8.0 million (Q2 2024), and -$11.6 million (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | -164.00 Mn |
| 10 | Regencell Bioscience Holdings | 2.74 Bn | 2.74 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2.48 Mn |
| Jun 30, 2024 | -7.96 Mn |
| Jun 30, 2023 | -11.61 Mn |
| Jun 30, 2022 | -16.40 Mn |
| Jun 30, 2021 | -59,413.00 |
| Jun 30, 2020 | -386,979.00 |